RxDoctor Payments Data

Markitta Brown, APRN

Psychiatric/Mental Health · London, KYNPI 1992157002

Payments from drug & device makers

$2,114in general payments, 2019–2025

Across 110 payments — averaging $19.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$285
  • Teva Pharmaceuticals USA, Inc.$284
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$185
  • Indivior Inc.$174
  • Axsome Therapeutics, Inc.$157
  • Braeburn Inc.$152
  • plus $877 from 13 others

What the payments were for

  • Food & beverage$2,114100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,114 in reported general payments places this provider in the 70th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$9,683
Medicare patients
12
Services billed
160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl34$49,730
MounjaroTirzepatide28$29,245
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl97$6,595
Quetiapine Fumarate31$371
Hydroxyzine Hcl34$332
Buspirone Hcl51$252
Ondansetron OdtOndansetron18$199
Duloxetine Hcl23$161
Ibuprofen20$161
Fluoxetine Hcl25$156
Omeprazole14$153
Bupropion XlBupropion Hcl18$137
Hydroxyzine Pamoate20$129
Escitalopram Oxalate28$104
Lisinopril32$87

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$285$49,73034 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in London

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →